ArticleInternational journal of general medicine2026
miR-1287-5p as a Biomarker for Predicting Lymph Node Metastasis in Gastric Cancer Patients.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The purpose of this study was to predict lymph node metastasis (LNM) in gastric cancer (GC) patients by constructing a nomogram. Methods: A total of 416 GC patients from the TCGA database and the Second Hospital of Hebei Medical University were included. The TCGA cohort was used to develop the prediction model. Logistic regression was used to determine risk factors associated with LNM in GC patients. A nomogram model was then developed. Model performance was evaluated using the area under the curve (AUC) and calibration curves. Results: In the multivariate analysis, the variables independently associated with LNM in GC patients were race (OR=1.820, 95% CI 1.060-3.125), histologic grade (OR=0.587, 95% CI 0.354-0.974), pathologic stage T3 or higher (OR=2.081, 95% CI 1.188-3.647) and miR-1287-5p (OR=0.748, 95% CI 0.565-0.992). A nomogram comprising the above four independent factors was constructed to calculate the possibility of LNM. The C-index values were 0.847 (95% CI 0.777-0.917) and 0.755 (95% CI 0.565-0.944) in the training and supportive cohorts, respectively. Conclusion: We identified miR-1287-5p as a novel predictor of LNM in GC patients. We established a nomogram model for predicting LNM in GC patients, and evaluated its performance in a supportive cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.